Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ONE-P TMS First Responders

NCT: NCT07773935 · NOT_YET_RECRUITING

NCT IDNCT07773935
StatusNOT_YET_RECRUITING
Start Date2026-11-01
Completion2029-01-01
SponsorFidel Vila-Rodriguez, MD, PhD, FRCPC, DFAPA (OTHER)
First posted
Last updated

Brief Summary

The aim of this study is to examine the feasibility and tolerability of a one-day protocol of repetitive transcranial magnetic stimulation with D-cycloserine (DCS) as an augmentation strategy in first responders who have PTSD.

Frequently Asked Questions

What is ONE-P TMS First Responders?

ONE-P TMS First Responders is a clinical trial registered under NCT07773935. Current status: NOT_YET_RECRUITING.

What is the status of NCT07773935?

The current status of NCT07773935 (ONE-P TMS First Responders) is: NOT_YET_RECRUITING.

When did ONE-P TMS First Responders start?

ONE-P TMS First Responders started on 2026-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.